End-stage renal disease in autosomal dominant polycystic kidney disease: A comparison of dialysis-related utilization and costs with other chronic kidney diseases

ClinicoEconomics and Outcomes Research

Volumn 7, Issue , 2015, Pages 65-72

  Brunelli, Steven M ^a   Blanchette, Christopher M ^b,c   Claxton, Ami J ^a   Roy, Debosree ^b   Rossetti, Sandro ^c   Gutierrez, Benjamin ^c  

^a DAVITA CLINICAL RESEARCH   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

ADPKD; Chronic kidney disease; Dialysis; Health care costs

Indexed keywords

ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE ELIGIBILITY; HOSPITALIZATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBSERVATIONAL STUDY; PARALLEL DESIGN; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; VERY ELDERLY;

EID: 84920983288     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S76269     Document Type: Article

References (18)

1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287–1301.
2. Chapman AB. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol. 2008;3(4):1197–1204.
3. Hildebrant F. Genetic kidney diseases. Lancet. 2010;375(9722): 1287–1295.
4. Iglesias CG, Torres VE, Offord K P, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis. 1983;2(6):630–639.
5. National Institutes of Health [webpage on the Internet]. Fact Sheet – Autosomal Dominant Polycystic Kidney Disease. Bethesda, MD: National Institutes of Health [updated March 29, 2013]. Available from: http://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=29. Accessed November 5, 2013.
6. Chapin HC, Caplan MJ. The cell biology of polycystic kidney disease. J Cell Biol. 2010;191(4):701–710.
7. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.
8. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736–3741.
9. Davison R, Sheerin NS. Prognosis and management of chronic kidney disease (CKD) at the end of life. Postgrad Med J. 2013;90(1060): 98–105.
10. Murtagh FE, Sheerin NS, Addington-Hall J, Higginson IJ. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011;6(7):1580–1590.
11. United States Renal Data System, 2013 Atlas of ESRD [document on the Internet]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from: http://www.usrds.org/atlas.aspx. Accessed March 2, 2014.
12. Centers for Medicare and Medicaid Services. 2013 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Woodlawn, MD: Centers for Medicare and Medicaid Services; 2013. Available from: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/Downloads/TR2013.pdf. Accessed March 2, 2014.
13. Lentine KL, Xiao H, Machnicki G, Gheorghian A, Schnitzler MA. Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol. 2010;5(8):1471–1479.
14. Centers for Medicare and Medical Services. Medicare Secondary Payer (MSP) Manual, 10.2 – End-Stage Renal Disease (ESRD). Woodlawn, MD: Centers for Medicare and Medical Services; 2005 [updated August 3, 2012]. Available from: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/msp105c01.pdf. Accessed May 16, 2014.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
16. Measuring Price Change for Medical Care in the CPI [webpage on the Internet]. Washington, DC: United States Department of Labor [updated April 12, 2010]. Available from: http://www.bls.gov/cpi/cpifact4.htm. Accessed May 28, 2014.
17. CMS Fast Facts Overview [webpage on the Internet]. Centers for Medicare and Medicaid Services [updated Jul 2014]. Available from: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Fast-Facts/index.html. Accessed May 19, 2014.
18. United States Renal Data System, 2013 Atlas of CKD [document on the Internet]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from: http://www.usrds.org/atlas.aspx. Accessed July 8, 2014.